Alnylam Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALNY and other ETFs, options, and stocks.

About ALNY

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference.

CEO

Yvonne L. Greenstreet

CEOYvonne L. Greenstreet

Employees

2,230

Employees2,230

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2002

Founded2002

Employees

2,230

Employees2,230

ALNY Key Statistics

Market cap

60.25B

Market cap60.25B

Price-Earnings ratio

-186.29

Price-Earnings ratio-186.29

Dividend yield

—

Dividend yield—

Average volume

989.17K

Average volume989.17K

High today

$462.63

High today$462.63

Low today

$448.95

Low today$448.95

Open price

$456.94

Open price$456.94

Volume

791.79K

Volume791.79K

52 Week high

$484.21

52 Week high$484.21

52 Week low

$205.87

52 Week low$205.87

ALNY News

Simply Wall St 1d

Did Amvuttra’s Phase 3 Update and ZENITH Trial Milestone Just Shift Alnylam’s Investment Narrative?

In recent days, Alnylam Pharmaceuticals reported updated Phase 3 data from the HELIOS-B study for Amvuttra, reinforcing its efficacy and safety in treating tran...

TipRanks 2d

Alnylam price target raised to $475 from $405 at Morgan Stanley

Morgan Stanley analyst Michael Ulz raised the firm’s price target on Alnylam (ALNY) to $475 from $405 and keeps an Equal Weight rating on the shares. The firm,...

TipRanks 4d

Alnylam Pharma Executives Unload Millions in Stock Sales!

New insider activity at Alnylam Pharma ( (ALNY) ) has taken place on October 3, 2025. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55%...

Analyst ratings

73%

of 30 ratings

Buy

73.3%

Hold

23.3%

Sell

3.3%

More ALNY News

TipRanks 4d

Alnylam Pharma Secures $500M Credit Agreement

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

Seeking Alpha 5d

Alnylam yanks Amvuttra TV ad following FDA letter - report

Alnylam Pharmaceuticals (NASDAQ:ALNY) has pulled a television ad for its drug Amvuttra (vutrisiran) after the U.S. FDA determined the spot was misleading. Amvu...

People also own

Based on the portfolios of people who own ALNY. This list is generated using Robinhood data, and it’s not a recommendation.

Eli Lilly

Vertex Pharmaceuticals

CrowdStrike Holdings

Netflix

Taiwan Semiconductor Manu…

Meta Platforms